Skip to main
SBRA
SBRA logo

SBRA Stock Forecast & Price Target

SBRA Analyst Ratings

Based on 9 analyst ratings
Hold
Strong Buy 0%
Buy 33%
Hold 67%
Sell 0%
Strong Sell 0%

Bulls say

Sabra Health Care REIT is demonstrating a positive outlook due to continued improvements in occupancy and rent coverage, coupled with an attractive valuation profile that supports growth potential. The expected recovery in the seniors housing managed portfolio is anticipated to enhance the company's leverage position, allowing it to pursue accretive growth opportunities effectively. Additionally, favorable healthcare real estate demand drivers, along with above-average RIDEA exposure, position Sabra to capitalize on market trends, and the revised FFO estimates indicate a positive trajectory for financial performance.

Bears say

Sabra Health Care REIT faces challenges in predicting operator performance, particularly as individual operators struggle with rent payments amid an inflationary environment. The company is not as low-leveraged as several peers and is trading near the high end of its 10-year stock valuation range, which suggests limited potential for immediate earnings accretion from acquisitions. Additionally, the current cost of equity presents constraints on profitability, further contributing to the negative outlook for its stock performance.

SBRA has been analyzed by 9 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 33% recommend Buy, 67% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Sabra Health Care and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Sabra Health Care (SBRA) Forecast

Analysts have given SBRA a Hold based on their latest research and market trends.

According to 9 analysts, SBRA has a Hold consensus rating as of Nov 26, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $20.56, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $20.56, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Sabra Health Care (SBRA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.